From Broad Protocols to Personalization
Precision medicine has revolutionized the way cancer is treated, shifting away from one-size-fits-all protocols towards strategies tailored to the individual. By analyzing the genetic and molecular profile of each tumor, oncologists can now select treatments that are more likely to be effective—and avoid those that won’t. This approach not only increases efficacy but also reduces adverse effects, ultimately leading to better patient outcomes.
At the heart of this transformation lies genomic and molecular profiling. Technologies such as next-generation sequencing (NGS) and comprehensive genomic profiling (CGP) enable clinicians to identify actionable mutations and biomarkers, offering a far more detailed understanding of cancer biology than ever before.
Multidisciplinary Teams: Making Precision Medicine Work
To bring precision medicine into daily practice, the role of Multidisciplinary Teams (MDTs) is essential. These teams bring together oncologists, pathologists, radiologists, geneticists, nurses, and other specialists to co-develop treatment plans based on a patient’s unique profile.
This collaborative approach ensures that all clinical perspectives are considered—from diagnosis through to treatment and follow-up. As new genomic and molecular data become available, MDTs are equipped to continuously evaluate and adapt treatment strategies in real time.
Why Genomic Profiling Matters
By identifying the molecular drivers of each cancer, clinicians can match patients with therapies that specifically target those pathways. This means:
• Higher response rates
• Longer progression-free survival
• Fewer side effects
• Reduced resistance to treatment
Take, for example, targeted therapies in lung cancer. Patients with specific EGFR mutations or ALK rearrangements have shown significant improvements in survival rates compared to those receiving traditional chemotherapy.
Is Precision Medicine Worth the Cost?
While genomic testing and targeted therapies can carry high upfront costs, evidence shows they are economically viable in the long term. Precision medicine helps avoid ineffective treatments, reduces hospitalizations, and minimizes complications—leading to substantial cost savings for healthcare systems. Moreover, by ensuring the right treatment for the right patient, resources are used more efficiently.
Precision medicine in oncology represents a significant leap forward in how we understand and treat cancer. But its full potential can only be unlocked through the collaboration of multidisciplinary teams. By combining advanced data with coordinated clinical expertise, we move closer to a future where every patient receives precisely the care they need—no more, no less.
Let’s discuss
At Vintura, we believe real breakthroughs happen when data and collaboration come together. Our team Poka Cui,Bas Amesz and Marcos Gallego Llorente, work closely with healthcare providers to embed precision medicine into everyday cancer care. Are you ready to make personalized care a reality? Let’s connect at ESMO AI this November to explore how we can shape the future of oncology together.
